黏合剂市场－全球产业规模、份额、趋势、机会、预测：按应用、类型、形状、地区和竞争格局划分，2021-2031年

全球外科硬脑膜黏合剂市场预计将从 2025 年的 2.1331 亿美元成长到 2031 年的 2.9597 亿美元，复合年增长率为 5.61%。

这些专用硬脑膜黏合剂在脊椎和神经外科手术中发挥着至关重要的作用，它们作为外科密封剂和黏合剂，密封硬脑膜以防止脑脊髓液渗漏。市场成长趋势主要受全球颅脑和脊椎手术频率增加的推动，而这又主要是由于人口老化和需要手术治疗的创伤性损伤病例不断增加所致。此外，减少术后併发症和缩短患者恢復时间等临床需求也强烈支持使用这些辅助密封剂，而不是仅依赖传统的缝合技术。

美国脊椎註册中心的数据凸显了这一日益增长的需求，预计到2025年，脊椎手术量将年增17.86%。儘管成长强劲，但市场扩张仍面临一个重大障碍：先进的合成和生物黏合剂产品成本高昂。这一经济障碍限制了预算紧张的发展中地区和医疗系统采用这些产品，从而阻碍了市场渗透。

市场驱动因素

脊椎和神经系统疾病的日益普遍是全球硬膜黏合剂市场的主要驱动因素，因为这些疾病通常需要进行复杂的手术，而硬膜修復在手术中至关重要。脊髓损伤和中枢神经系统恶性肿瘤的高发生率直接增加了需要安全密封以防止脑脊髓液渗漏的手术数量。根据美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告，美国预计将诊断出24,820例脊髓或脑部恶性肿瘤病例。全球创伤数据也印证了这庞大的患者数量。发表于2025年1月《老化研究评论》的一项题为《全球、区域和国家脊髓损伤负担》的研究报告指出，在最近一个分析年份，全球脊髓损伤病例数达到574,502例，凸显了持续寻求能够最大限度降低术后风险的手术解决方案的必要性。

此外，合成和生物相容性硬脑膜密封剂技术的创新正在加速市场接受度，满足了临床上对有效预防渗漏的迫切需求。与传统缝合线相比，外科医生越来越多地采用先进的水凝胶和基质，这些材料能够增强组织黏附性并降低併发症率。这些最尖端科技的市场成功体现在领先的再生医学解决方案提供者的财务表现。例如，Integra Life Sciences 在 2024 年 11 月发布的 2024 年第三季财报中指出，其组织技术部门（包括硬脑膜修復产品）的收入达到 1.101 亿美元。这一数字凸显了医疗机构在高品质黏合剂方面的大量投资，以确保最佳的康復效果并减少昂贵的再次入院。

市场挑战

先进的合成和生物硬铝黏合剂的高昂购置成本严重阻碍了其在全球外科手术中的广泛应用。儘管这些产品具有明显的临床优势，但其高昂的价格往往超出了许多医疗机构的预算，尤其是公共医疗系统和麵临财政严格限制的发展中地区。因此，采购部门和外科医生常常被迫选择更经济的替代方案，例如传统缝合线，尤其是在常规手术中，因为在这些手术中，密封剂的额外成本并非绝对必要。

医疗产业营运成本的不断上涨加剧了这种经济压力，限制了其购买高品质手术辅助器具的能力。根据美国医院协会的数据，预计到2024年，医院总支出将增加5.1%，这一数字比整体经济通膨率高出数十亿以金额为准。日益沉重的财务负担迫使医疗机构采取严格的成本削减措施，这往往导致昂贵且非必要的医疗用品采购减少。因此，硬脑膜黏合剂生产商在进入那些价格敏感度高于对先进术后护理解决方案需求的市场时面临挑战。

市场趋势

专为微创神经外科手术设计的施用器不断革新，正在改变硬脑膜黏合剂的使用方式。随着外科医生越来越多地选择锁孔开颅术和经鼻内视镜技术，传统的注射器给药方法已无法满足进入深部狭窄手术通道的需求。为此，製造商推出了柔性可伸缩的导管式施用器和喷嘴。这些施药器能够将密封剂精确、可控制地应用于难以触及的硬脑膜缺损处，且不会阻碍手术视野。这项发展满足了操作简便性和在狭小空间内高效操作的关键工作流程需求，直接推动了微创手术的发展。此类以使用者为中心的手术器械的商业性吸引力从主要市场参与者的财务表现中可见一斑。在2024年11月发布的2024年第三季财报中，百特国际公司公布其先进外科业务部门的销售额为2.72亿美元，年增7%，这主要得益于市场对其密封剂和止血产品组合的强劲需求。

同时，完全可生物降解和可生物吸收的配方正成为一种显着趋势，旨在改善长期术后效果。传统的密封剂通常会留下永久性残留物，而目前的趋势是使用水凝胶基质，这种基质可在通常为30至45天的可预测时间内透过水解完全分解。这项特性对于避免残留物压迫神经组织的「占位效应」至关重要，同时也能防止黏合剂在后续MRI扫描中错误地显示肿瘤復发。永久性或渗透性的产品经常会遇到这种挑战，这表明影像清晰度和「清洁」癒合正成为复杂颅脑和脊椎手术的先决条件。该领域对高度生物相容性和高性能解决方案的需求规模庞大。根据Medtronic公司于2024年5月发布的“2024年全年及第四季度财务业绩报告”，该公司神经科学产品组合创造了94亿美元的收入，这表明支持复杂神经系统修復的先进技术拥有广阔的市场。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球外科黏合剂市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域（颅脑手术、脊椎手术）
  • 按类型（聚乙二醇、其他（纤维蛋白黏合剂））
  • 按形式（密封胶、密封膜）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美外科黏合剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲黏合剂黏合剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区黏合剂黏合剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲黏合剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲黏合剂黏合剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球外科黏合剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medprin Biotech GmbH
• Integra LifeSciences Corporation
• Pramand LLC
• Stryker Corporation
• DuraStat, Inc.
• Medtronic plc
• Becton, Dickinson and Company
• Regenity Biosciences
• Baxter International, Inc.
• Johnson & Johnson

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dural Adhesive Agent for Surgical Market is projected to expand from USD 213.31 Million in 2025 to USD 295.97 Million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 5.61%. These specialized dural adhesive agents serve as essential surgical sealants and glues during spinal and neurosurgical operations, functioning to seal the dura mater and avert cerebrospinal fluid leakage. The market's upward trajectory is largely propelled by an increasing global frequency of cranial and spinal surgeries, a trend driven by an aging demographic and a higher prevalence of traumatic injuries necessitating operative care. Furthermore, the clinical priority to reduce post-surgical complications and accelerate patient recovery times strongly favors the use of these adjunctive sealants over relying solely on traditional suturing techniques.

Data from the American Spine Registry highlights this growing demand, recording a 17.86% surge in submitted spine procedures in 2025 compared to the prior year, signaling a strong increase in surgical volume. Despite this robust growth, market expansion faces a notable obstacle regarding the substantial costs linked to advanced synthetic and biological adhesive products. This financial barrier limits their widespread implementation within developing regions and healthcare systems operating under tight budget constraints, hindering broader market penetration.

Market Driver

The escalating prevalence of spinal and neurological disorders acts as the primary driver for the global dural adhesive agent market, as these conditions often require intricate surgeries where dural repair is essential. The high frequency of spinal injuries and central nervous system malignancies directly increases the number of procedures necessitating reliable sealing to prevent cerebrospinal fluid leaks. According to the 'Cancer Facts & Figures 2025' report by the American Cancer Society in January 2025, it was projected that 24,820 malignant tumors of the spinal cord or brain would be diagnosed in the United States. This significant patient load is further corroborated by global trauma data; a study published in Ageing Research Reviews in January 2025 titled 'Global, regional, and national burden of spinal cord injury...' noted that global spinal cord injury cases reached 574,502 in the latest analysis year, highlighting the persistent need for surgical solutions to minimize post-operative risks.

Furthermore, innovations in synthetic and biocompatible dural sealant technologies are hastening market acceptance by satisfying the urgent clinical requirement for effective leak prevention. Surgeons are progressively adopting advanced hydrogels and matrices that provide enhanced tissue adhesion and lower complication rates relative to conventional sutures. The market success of these cutting-edge technologies is reflected in the financial results of leading regenerative solution providers. For instance, Integra LifeSciences reported in its 'Third Quarter 2024 Financial Results' in November 2024 that its Tissue Technologies segment, which includes its dural repair products, achieved 110.1 million dollars in revenue. This figure underscores the substantial investment by healthcare providers in premium adhesive agents to secure optimal recovery outcomes and reduce costly hospital readmissions.

Market Challenge

The substantial acquisition costs linked to advanced synthetic and biological dural adhesives create a significant impediment to their ubiquitous adoption across the global surgical landscape. Although these products provide distinct clinical advantages, their premium price points often surpass the budgetary constraints of numerous healthcare facilities, especially within public health systems and developing regions subject to rigorous financial limits. Consequently, procurement departments and surgeons frequently encounter pressure to favor more economical alternatives, such as traditional sutures, particularly during routine operations where the additional cost of a sealant may not be considered strictly essential.

This economic pressure is exacerbated by increasing operational expenditures within the healthcare industry, which constrain the ability to purchase premium surgical adjuncts. Data from the American Hospital Association indicates that in 2024, total hospital expenses rose by 5.1%, a rate significantly exceeding general economic inflation. This mounting financial load forces medical institutions to adopt strict cost-containment measures, frequently leading to decreased procurement of expensive, non-mandatory medical supplies. As a result, dural adhesive manufacturers encounter challenges in expanding into markets where price sensitivity overrides the demand for sophisticated post-operative care solutions.

Market Trends

The evolution of applicators designed specifically for minimally invasive neurosurgery is reshaping how dural adhesive agents are utilized. With surgeons increasingly favoring keyhole craniotomies and endoscopic endonasal techniques, traditional syringe-based delivery methods have become insufficient for accessing deep, narrow surgical pathways. In response, manufacturers are launching flexible, extended catheter-based applicators and spray tips that enable the precise, controlled application of sealants in difficult-to-reach dural defects without obscuring the surgical field. This development addresses the vital workflow requirement for ease of use and efficiency in confined spaces, directly bolstering the growth of minimally invasive procedures. The commercial appeal of such user-focused surgical tools is evident in the financial performance of major market players; Baxter International Inc. reported in its 'Third Quarter 2024 Results' in November 2024 that its Advanced Surgery segment achieved sales of 272 million dollars, a 7% rise attributed to robust demand for its sealant and hemostat portfolio.

Concurrently, there is a marked transition toward fully biodegradable and bioabsorbable formulations engineered to enhance long-term post-surgical results. Unlike previous sealant generations that often left permanent residue, current trends favor hydrogel matrices that completely degrade through hydrolysis within a predictable period, usually between 30 and 45 days. This property is crucial for avoiding the "mass effect," wherein residual material compresses neural tissue, and for ensuring the adhesive does not simulate tumor recurrence on follow-up MRI scans, a frequent problem with permanent or radio-opaque products. This emphasis on imaging clarity and "clean" healing is becoming a prerequisite for complex cranial and spinal surgeries. The magnitude of the sector requiring these biocompatible, high-performance solutions is significant; Medtronic's 'Full Year and Fourth Quarter Fiscal 2024 Financial Results' from May 2024 revealed that its Neuroscience Portfolio generated 9.4 billion dollars in revenue, highlighting the extensive market for advanced technologies supporting intricate nervous system repairs.

Key Market Players

• Medprin Biotech GmbH
• Integra LifeSciences Corporation
• Pramand LLC
• Stryker Corporation
• DuraStat, Inc.
• Medtronic plc
• Becton, Dickinson and Company
• Regenity Biosciences
• Baxter International, Inc.
• Johnson & Johnson

Report Scope

In this report, the Global Dural Adhesive Agent for Surgical Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dural Adhesive Agent for Surgical Market, By Application

• Cranial Surgery
• Spinal Surgery

Dural Adhesive Agent for Surgical Market, By Type

• Polyethylene glycol
• Others (Fibrin Glue)

Dural Adhesive Agent for Surgical Market, By Form

• Sealant Glue
• Sealant Film

Dural Adhesive Agent for Surgical Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dural Adhesive Agent for Surgical Market.

Available Customizations:

Global Dural Adhesive Agent for Surgical Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dural Adhesive Agent for Surgical Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Cranial Surgery, Spinal Surgery)
  • 5.2.2. By Type (Polyethylene glycol, Others (Fibrin Glue))
  • 5.2.3. By Form (Sealant Glue, Sealant Film)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Dural Adhesive Agent for Surgical Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Type
  • 6.2.3. By Form
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dural Adhesive Agent for Surgical Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Form
  • 6.3.2. Canada Dural Adhesive Agent for Surgical Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Form
  • 6.3.3. Mexico Dural Adhesive Agent for Surgical Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Form

7. Europe Dural Adhesive Agent for Surgical Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Type
  • 7.2.3. By Form
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dural Adhesive Agent for Surgical Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Form
  • 7.3.2. France Dural Adhesive Agent for Surgical Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Form
  • 7.3.3. United Kingdom Dural Adhesive Agent for Surgical Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Form
  • 7.3.4. Italy Dural Adhesive Agent for Surgical Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Form
  • 7.3.5. Spain Dural Adhesive Agent for Surgical Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Form

8. Asia Pacific Dural Adhesive Agent for Surgical Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Type
  • 8.2.3. By Form
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dural Adhesive Agent for Surgical Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Form
  • 8.3.2. India Dural Adhesive Agent for Surgical Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Form
  • 8.3.3. Japan Dural Adhesive Agent for Surgical Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Form
  • 8.3.4. South Korea Dural Adhesive Agent for Surgical Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Form
  • 8.3.5. Australia Dural Adhesive Agent for Surgical Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Form

9. Middle East & Africa Dural Adhesive Agent for Surgical Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Type
  • 9.2.3. By Form
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dural Adhesive Agent for Surgical Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Form
  • 9.3.2. UAE Dural Adhesive Agent for Surgical Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Form
  • 9.3.3. South Africa Dural Adhesive Agent for Surgical Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Form

10. South America Dural Adhesive Agent for Surgical Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Type
  • 10.2.3. By Form
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dural Adhesive Agent for Surgical Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Form
  • 10.3.2. Colombia Dural Adhesive Agent for Surgical Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Form
  • 10.3.3. Argentina Dural Adhesive Agent for Surgical Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dural Adhesive Agent for Surgical Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medprin Biotech GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Integra LifeSciences Corporation
• 15.3. Pramand LLC
• 15.4. Stryker Corporation
• 15.5. DuraStat, Inc.
• 15.6. Medtronic plc
• 15.7. Becton, Dickinson and Company
• 15.8. Regenity Biosciences
• 15.9. Baxter International, Inc.
• 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer